JUBILANT PHARMOVA
Quarterly Results Analysis [Dec2023]
JUBILANT PHARMOVA Quarterly Results
Consolidated | Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
Dec2022 UnAudited |
Sep2022 UnAudited |
Jun2022 UnAudited |
Mar2022 Audited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹1,677 Cr | ₹1,680 Cr | ₹1,587 Cr | ₹1,678 Cr | ₹1,553 Cr | ₹1,600 Cr | ₹1,452 Cr | ₹1,528 Cr |
Expenses | ₹1,459 Cr | ₹1,439 Cr | ₹1,417 Cr | ₹1,459 Cr | ₹1,407 Cr | ₹1,381 Cr | ₹1,259 Cr | ₹1,280 Cr |
Operating Income | ₹218 Cr | ₹242 Cr | ₹170 Cr | ₹219 Cr | ₹146 Cr | ₹219 Cr | ₹192 Cr | ₹247 Cr |
Other Income | ₹36 Cr | ₹10 Cr | ₹9 Cr | ₹4 Cr | ₹10 Cr | ₹13 Cr | ₹11 Cr | ₹-3 Cr |
Interest | ₹71 Cr | ₹66 Cr | ₹62 Cr | ₹56 Cr | ₹51 Cr | ₹42 Cr | ₹40 Cr | ₹40 Cr |
Depreciation | ₹95 Cr | ₹97 Cr | ₹90 Cr | ₹271 Cr | ₹94 Cr | ₹94 Cr | ₹95 Cr | ₹101 Cr |
Profit Before Tax | ₹88 Cr | ₹89 Cr | ₹27 Cr | ₹-103 Cr | ₹10 Cr | ₹39 Cr | ₹69 Cr | ₹104 Cr |
Profit After Tax | ₹53 Cr | ₹53 Cr | ₹7 Cr | ₹-117 Cr | ₹-14 Cr | ₹8 Cr | ₹47 Cr | ₹58 Cr |
EPS | ₹4.23 | ₹3.96 | ₹0.41 | ₹-6.15 | ₹-0.98 | ₹0.34 | ₹2.96 | ₹3.74 |
Industry Peers & Returns | 1W | 1M | 1Y |
JUBILANT PHARMOVA | 1.7% | 18.7% | 122.1% |
SUN PHARMACEUTICAL INDUSTRIES | -0.1% | -2.8% | 50.3% |
CIPLA | 4.5% | -3.1% | 52.8% |
DR REDDYS LABORATORIES | 4.6% | 1.4% | 22.2% |
ZYDUS LIFESCIENCES | 3.1% | -4.1% | 80.4% |
DIVIS LABORATORIES | 4.7% | 10.8% | 18.1% |
MANKIND PHARMA | 2.7% | 12.4% | NA |
TORRENT PHARMACEUTICALS | 6.1% | 5.3% | 66.2% |
LUPIN | 3.1% | -1.1% | 127.4% |
JUBILANT PHARMOVA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -0.19 % |
Y-o-Y | 8.03 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2023 | ₹1,677 Cr | -0.19 | |
Sep2023 | ₹1,680 Cr | 5.89 | |
Jun2023 | ₹1,587 Cr | -5.43 | |
Mar2023 | ₹1,678 Cr | 8.08 | |
Dec2022 | ₹1,553 Cr | -2.94 | |
Sep2022 | ₹1,600 Cr | 10.18 | |
Jun2022 | ₹1,452 Cr | -4.96 | |
Mar2022 | ₹1,528 Cr | - |
JUBILANT PHARMOVA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -9.84 % |
Y-o-Y | 49.42 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2023 | ₹218 Cr | -9.84 | |
Sep2023 | ₹242 Cr | 42.57 | |
Jun2023 | ₹170 Cr | -22.63 | |
Mar2023 | ₹219 Cr | 50.25 | |
Dec2022 | ₹146 Cr | -33.29 | |
Sep2022 | ₹219 Cr | 13.67 | |
Jun2022 | ₹192 Cr | -22.22 | |
Mar2022 | ₹247 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | -9.66 % |
Y-o-Y | 38.30 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2023 | 13% | -9.66 | |
Sep2023 | 14.39% | 34.61 | |
Jun2023 | 10.69% | -18.15 | |
Mar2023 | 13.06% | 38.94 | |
Dec2022 | 9.4% | -31.24 | |
Sep2022 | 13.67% | 3.17 | |
Jun2022 | 13.25% | -18.16 | |
Mar2022 | 16.19% | - |
JUBILANT PHARMOVA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 0.38 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2023 | ₹53 Cr | 0.38 | |
Sep2023 | ₹53 Cr | 617.57 | |
Jun2023 | ₹7 Cr | Positive | |
Mar2023 | ₹-117 Cr | Negative | |
Dec2022 | ₹-14 Cr | Negative | |
Sep2022 | ₹8 Cr | -83.80 | |
Jun2022 | ₹47 Cr | -18.79 | |
Mar2022 | ₹58 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 0.63 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2023 | 3.18 % | 0.63 | |
Sep2023 | 3.16 % | 572.34 | |
Jun2023 | 0.47 % | Positive | |
Mar2023 | -6.99 % | Negative | |
Dec2022 | -0.93 % | Negative | |
Sep2022 | 0.48 % | -85.14 | |
Jun2022 | 3.23 % | -14.55 | |
Mar2022 | 3.78 % | - |
JUBILANT PHARMOVA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 6.82 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2023 | ₹4.23 | 6.82 | |
Sep2023 | ₹3.96 | 865.85 | |
Jun2023 | ₹0.41 | Positive | |
Mar2023 | ₹-6.15 | Negative | |
Dec2022 | ₹-0.98 | Negative | |
Sep2022 | ₹0.34 | -88.51 | |
Jun2022 | ₹2.96 | -20.86 | |
Mar2022 | ₹3.74 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD